Rfp Financial Group LLC Abbott Laboratories Transaction History

Rfp Financial Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$100.73 - $112.44 $1,208 - $1,349	12 Added 1.8%	678 $70,000
Q1 2024 May 09, 2024	SELL	$109.52 - $120.96 $16,208 - $17,902	-148 Reduced 18.18%	666 $75,000
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $90 - $110	1 Added 0.12%	814 $89,000
Q3 2023 Oct 30, 2023	BUY	$95.53 - $114.62 $95 - $114	1 Added 0.12%	813 $78,000
Q2 2023 Aug 01, 2023	BUY	$100.78 - $112.29 $16,729 - $18,640	166 Added 25.7%	812 $88,000
Q4 2022 Jan 24, 2023	BUY	$95.06 - $111.52 $61,408 - $72,041	646 New	646 $70.9 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Rfp Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Rfp Financial Group LLC with notifications on news.